Answers are grounded in this paper and cite their sources.
Despite advancements in cystic fibrosis (CF) therapeutics, the persistence of chronic infections necessitates continued use of nebulized therapies. Though the Cystic Fibrosis Foundation recommends well-defined cleaning and disinfection of nebulizers to mitigate pathogen exposure risks, discrepancies between Cystic Fibrosis Foundation guidelines, manufacturers' instructions, and variability in center recommendations contribute to confusion and non-standardized practices.
No takes yet. Share an insight, caveat, or question.
Kenkare et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: